参考文献/References:
[1] 祝之明.代谢性心血管病:理念、挑战与实践[J].中华心血管病杂志,2021,49(7):650-655.?div>[2] 国家心血管病医疗质量控制中心,National Center for Cardiovascular Quality Improvement.《2021年中国心血管病医疗质量报告》概要[J].中国循环杂志,2021,36(11):1041-1064.[3] 陈绍良,吴永健.心脏病学实践2022[M].第1版.北京:人民卫生出版社,2022:160-163.
[4] Kim MK,Han K,Park YM,et al. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body mass index with mortality and cardiovascular outcomes in the general population[J]. Circulation,2018,138(23):2627-2637.
[5] Ralston J,Nugent R.Toward a broader response to cardiometabolic disease[J].Nat Med,2019,25(11):1644-1646.?/div>
[6] 张凤梅,王淑云,徐恒戬.某高校教职工心血管代谢性危险因素患病状况分析[J].医学理论与实践,2021,34(9):1602-1604.
[7] Ziaeian B,Fonarow GC. Epidemiology and aetiology of heart failure[J]. Nat Rev Cardiol,2016,13(6):368-378.?/div>
[8] Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.?/div>
[9] Davidson KW,Bigger JT,Burg MM,et al. Centralized,stepped,patient preference-based treatment for patients with post-acute coronary syndrome depression:CODIACS vanguard randomized controlled trial[J]. JAMA Intern Med,2013,173(11):997-1004.
[10] Janssen V,de Gucht V,Dusseldorp E,et al. Lifestyle modification programmes for patients with coronary heart disease:a systematic review and meta-analysis of randomized controlled trials[J]. Eur J Prev Cardiol,2013,20(4):620-640.?/div>
[11] Richards SH,Anderson L,Jenkinson CE,et al. Psychological interventions for coronary heart disease:Cochrane systematic review and meta-analysis[J]. Eur J Prev Cardiol,2018,25(3):247-259.?/div>
[12] 崔虹.基于积极心理学理论的心理干预对老年冠心病患者心血管不良事件及再住院率的影响[J].现代临床护理,2021,20(11):43-47.?/div>
[13] 张佳.基于护理个案管理的全程心理干预对急性心肌梗死心血管事件发生率的影响[J].护理实践与研究,2021,18(18):2744-2747.
[14] 周卫,袁源,叶鹏.伊朗儿童和青少年的垃圾食品消费与心脏代谢危险因素之间的关系[J].中华高血压杂志,2020,28(10):999.?/div>
[15] Artinian NT,Fletcher GF,Mozaffarian D,et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults:a scientific statement from the American Heart Association[J]. Circulation,2010,122(4):406-441.?/div>
[16] Chiavarino C,Cavallero E,Rabellino D,et al. Mental Fitness for patients with acute coronary syndrome:A randomized clinical trial[J]. Br J Health Psychol,2016,21(3):584-599.?/div>
[17] Pristipino C,Roncella A,Pasceri V,et al. Short-TErm psychotherapy in acute myocardial infarction (STEP-IN-AMI) trial:final results[J]. Am J Med,2019,132:639-646.e635.?/div>
[18] Mach F,Baigent C,Catapano AL,et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias:lipid modification to reduce cardiovascular risk[J]. Eur Heart J,2020,41(1):111-188.?/div>
[19] 芦燕玲..不同心理趋向功能社区人群心血管代谢指标的干预研究[J].中华健康管理学杂志,2012,6(6):376-379.
[20] 宗允.心理暗示联合合理限食疗法对糖尿病患者血糖和血脂代谢及心理弹性的干预效果[J].中华预防医学杂志,2022,56(3):346-350.
[21] Whelton PK,Carey RM,Aronow WS,et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension[J]. Circulation,2018,71(6):e13-e115.
[22] Conversano C,Orrù G,Pozza A,et al. Is mindfulness-based stress reduction effective for people with hypertension? A systematic review and meta-analysis of 30 years of evidence[J]. Int J Environ Res Public Health,2021,18(6):2882.?/div>
[23] 杨敏,杨洋,王丽娜.认知-存在团体干预结合个体化生活方式管理对老年原发性高血压患者血压变异性、健康行为及心理状态的影响[J].临床医学研究与实践,2022,7(29):154-157,161.?/div>
[24] 许慧艳,吕聪敏,李莉,等.生理心理社会综合诊疗对原发性高血压的疗效观察[J].医学与哲学(B),2018,39(9):41-45.
[25] Zhang F,Zhang Y,Jiang N,et al. Influence of mindfulness and relaxation on treatment of essential hypertension:meta-analysis[J]. J Healthc Eng,2021,2021:69-72.?/div>
[26] Sherling DH,Perumareddi P,Hennekens CH. Metabolic syndrome[J]. J Cardiovasc Pharmacol Ther,2017,22(4):365-367.
[27] 熊芳,余超,祝玲娟,等.高血压人群不同胰岛素抵抗指数与高尿酸血症的相关性[J].中国医学科学院学报,2023,45(3):390-398.
[28] Gulley LD,Shomaker LB,Kelly NR,et al. Examining cognitive-behavioral therapy change mechanisms for decreasing depression, weight, and insulin resistance in adolescent girls at risk for type 2 diabetes[J]. J Psychosom Res,2022,157:110781.?/div>
[29] Kim M,Kim Y,Go Y,et al. Multidimensional cognitive behavioral therapy for obesity applied by psychologists using a digital platform:open-label randomized controlled trial[J]. JMIR Mhealth Uhealth,2020,8(4):e14817.?/div>
[30] 王娟,徐丽,刘翔,等.焦虑情绪对2型糖尿病患者胰岛素抵抗、胰岛细胞功能及相关指标的影响[J].宁夏医学杂志,2021,43(12):1159-1161.?/div>
[31] 刁艳,赵锦仲,陈少华.心理护理联合常规护理在老年人早期糖尿病肾病患者中的应用效果[J].中国当代医药,2019,26(27):210-212.?/div>
[32] Jalali D,Abdolazimi M,Alaei Z,et al. Effectiveness of mindfulness-based stress reduction program on quality of life in cardiovascular disease patients[J]. Int J Cardiol Heart Vasc,2019,23:100356.
[33] Celano CM,Golden J,Healy BC,et al. Predictors of completion and response to a psychological intervention to promote health behavior adherence in heart failure[J]. Int J Psychiatry Med,2022,57(1):21-34.?/div>
[34] 周静,徐静,唐碧,等.心理护理与音乐疗法对难治性心力衰竭患者身心的影响[J].中华全科医学,2015,13(7):1185-1187.
[35] 莫展屏,麦玉芳,姚雪霞.多学科护理联合心理干预对2型糖尿病合并高血压患者的影响[J].心理月刊,2022,17(12):107-109.
[36] 范玲莉.分级心理干预联合系统化健康教育对发热门诊留诊观察患者的影响[J].卫生职业教育,2022,40(21):154-156.
[37] 李志强,王春燕,严晓沁,等.双心医学模式对慢性心力衰竭合并抑郁和焦虑障碍病人的管理作用[J].中西医结合心脑血管病杂志,2020,18(23):4006-4010.?/div>
[38] 王俐达,李忠艳. 浅谈"双心医学"诊疗模式[J].中华医学信息导报,2022,37(15) :16-17.?/div>
[39] Hernandez R,Daviglus ML,Martinez L,et al. "iAlegrate!"-A culturally adapted positive psychological intervention for Hispanics/Latinos with hypertension:rationale,design,and methods[J]. Contemp Clin Trials Commun,2019,14:100348.?/div>
[40] Hernandez R,Cohn M,Hernandez A,et al. A web-based positive psychological intervention to improve blood pressure control in spanish-speaking hispanic/latino adults with uncontrolled hypertension:protocol and design for the alégrate randomized controlled trial[J]. JMIR Res Protoc,2020,9(8):e17721.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(10):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(10):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(10):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(10):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(10):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(10):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]